Nipro, preparing for the future with a new CEO

2020 - As the year of change

Stephan Arnold, CEO Nipro PharmaPackaging International

Scarcity in the "glass tubing" market, ever increasing scrutiny regarding "regulatory & quality" in the pharmaceutical packaging market... all lead to the necessity for us to invest in capacity, as well as new technology, to yield even higher quality.  

Nipro's R&D & Engineering team is working fiercely to finalize the development of novel technologies within the process of converting of pre-fillable syringes.

As we start this new decade with its many challenges, we are delighted to inform that Mr. Stephan Arnold has joined Nipro PharmaPackaging International as its new CEO.  
We also want to thank our former CEO, Mr Minoru Takeuchi. He will take on a new role as Global Business Development in"glass pharmaceutical packaging", with a clear focus on portfolio and region expansion, therefore working closely together with R&D.

A promising future!

With 20+ years in this industry, I can honestly state that I have found here a strong team of dedicated professionals. It is only fair to say that Nipro PharmaPackaging has a very solid backbone to further build upon. While respecting the traditions and history of the individual manufacturing plants, Nipro wants to instill the typical Japanese quality mindset. It demonstrates its great ambition by heavily investing in volume and quality, all with the aim of becoming the preferred partner to many pharmaceutical companies.
I take great pride in having joined Nipro in my new role as CEO. Nipro is on a mission to improve quality of life and patient outcomes across the globe. I look forward to contributing to this mission together with all of my new colleagues.
 

 

12.02.2020, Nipro PharmaPackaging International

News material on the Site is copyright and belongs to the Company or to its third party news provider, and all rights are reserved. Any User who accesses such material may do so only for its own personal use, and the use of such material is at the sole risk of the User. Redistribution or other commercial exploitation of such news material is expressly prohibited. Where such news material is provided by a third party, each User agrees to observe and be bound by the specific terms of use applying to such news material. We do not represent or endorse the accuracy or reliability of any of the info contained in any news or external websites referred to in the news.

Should the content or the design of these sites violate third parties rights or legal prescriptions, we kindly ask you to send us a respective message without invoice or cost. We guarantee that passages where the claim is considered as justified will be removed immediately, without any necessity to involve any lawyer into this issue. We will reject any claim caused by submission of a honorary note in this regard without any prior contact and confirmation of the issueby us and we reserve the right ssue counter claim ourselves because of violation of aforesaid conditions.